SK284899B6 - Medziprodukty na výrobu inhibítorov HIV-proteázy a spôsoby výroby inhibítorov HIV-proteázy - Google Patents

Medziprodukty na výrobu inhibítorov HIV-proteázy a spôsoby výroby inhibítorov HIV-proteázy Download PDF

Info

Publication number
SK284899B6
SK284899B6 SK282-99A SK28299A SK284899B6 SK 284899 B6 SK284899 B6 SK 284899B6 SK 28299 A SK28299 A SK 28299A SK 284899 B6 SK284899 B6 SK 284899B6
Authority
SK
Slovakia
Prior art keywords
group
formula
compound
alkyl
acid
Prior art date
Application number
SK282-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK28299A3 (en
Inventor
Kathleen R. Whitten
Michael E. Deason
Original Assignee
Agouron Pharmaceuticals, Inc.
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc., Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of SK28299A3 publication Critical patent/SK28299A3/sk
Publication of SK284899B6 publication Critical patent/SK284899B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK282-99A 1996-09-05 1997-09-04 Medziprodukty na výrobu inhibítorov HIV-proteázy a spôsoby výroby inhibítorov HIV-proteázy SK284899B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05
PCT/US1997/015468 WO1998009951A2 (en) 1996-09-05 1997-09-04 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors

Publications (2)

Publication Number Publication Date
SK28299A3 SK28299A3 (en) 1999-11-08
SK284899B6 true SK284899B6 (sk) 2006-02-02

Family

ID=24845703

Family Applications (2)

Application Number Title Priority Date Filing Date
SK282-99A SK284899B6 (sk) 1996-09-05 1997-09-04 Medziprodukty na výrobu inhibítorov HIV-proteázy a spôsoby výroby inhibítorov HIV-proteázy
SK90-2005A SK285278B6 (sk) 1996-09-05 1997-09-04 Spôsob výroby inhibítora HIV-proteázy

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK90-2005A SK285278B6 (sk) 1996-09-05 1997-09-04 Spôsob výroby inhibítora HIV-proteázy

Country Status (33)

Country Link
EP (2) EP1361216B1 (zh)
JP (3) JP4149000B2 (zh)
KR (1) KR100563289B1 (zh)
CN (2) CN1183117C (zh)
AP (2) AP1322A (zh)
AT (2) ATE254603T1 (zh)
AU (2) AU740369B2 (zh)
BG (2) BG64793B1 (zh)
BR (1) BR9713192A (zh)
CA (1) CA2264756A1 (zh)
CZ (2) CZ298175B6 (zh)
DE (2) DE69734689T2 (zh)
DK (2) DK1361216T3 (zh)
EA (1) EA002051B1 (zh)
EE (1) EE04465B1 (zh)
ES (2) ES2210573T3 (zh)
GE (1) GEP20022799B (zh)
HK (1) HK1062171A1 (zh)
HU (1) HUP0000028A3 (zh)
IL (1) IL128567A (zh)
IS (1) IS2030B (zh)
NO (1) NO313287B1 (zh)
NZ (1) NZ334909A (zh)
OA (1) OA10988A (zh)
PL (2) PL198408B1 (zh)
PT (1) PT927165E (zh)
SG (1) SG94780A1 (zh)
SI (2) SI0927165T1 (zh)
SK (2) SK284899B6 (zh)
TR (1) TR199900473T2 (zh)
UA (1) UA67727C2 (zh)
WO (1) WO1998009951A2 (zh)
YU (1) YU11599A (zh)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
WO1996028423A1 (fr) * 1995-03-15 1996-09-19 Sankyo Company, Limited Composes dipeptidiques de structure ahpba
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
EP0983999B8 (en) * 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
US6121468A (en) * 1995-09-26 2000-09-19 Japan Tobacco Inc. Process for producing amide derivatives and intermediate compounds
TR199801648T2 (xx) * 1996-02-24 1998-11-23 Basf Aktiengesellschaft Herbisid olarak pirazol-4-il-hetaroil t�revleri

Also Published As

Publication number Publication date
AP9901497A0 (en) 1999-06-30
JP2008056693A (ja) 2008-03-13
SI1361216T1 (sl) 2006-02-28
EP0927165B1 (en) 2003-11-19
IL128567A (en) 2004-03-28
EE04465B1 (et) 2005-04-15
NO991072D0 (no) 1999-03-04
AU1473602A (en) 2002-03-14
PL201758B1 (pl) 2009-05-29
EA002051B1 (ru) 2001-12-24
ES2252586T3 (es) 2006-05-16
IS2030B (is) 2005-08-15
EP0927165A2 (en) 1999-07-07
CZ71699A3 (cs) 1999-06-16
PL198408B1 (pl) 2008-06-30
CN1232455A (zh) 1999-10-20
GEP20022799B (en) 2002-09-25
PL331801A1 (en) 1999-08-02
WO1998009951A3 (en) 1998-07-09
EP1361216B1 (en) 2005-11-16
JP4149000B2 (ja) 2008-09-10
BG65237B1 (bg) 2007-09-28
HUP0000028A2 (hu) 2000-05-28
DE69726298T2 (de) 2004-05-27
DK1361216T3 (da) 2006-01-23
OA10988A (en) 2001-11-01
DK0927165T3 (da) 2004-03-15
SG94780A1 (en) 2003-03-18
KR100563289B1 (ko) 2006-03-22
YU11599A (sh) 2000-03-21
IL128567A0 (en) 2000-01-31
HK1062171A1 (en) 2004-10-21
SK28299A3 (en) 1999-11-08
EP1361216A1 (en) 2003-11-12
NO313287B1 (no) 2002-09-09
CN1183117C (zh) 2005-01-05
EE9900109A (et) 1999-12-15
EA199900257A1 (ru) 1999-08-26
KR20010029489A (ko) 2001-04-06
JP2008088178A (ja) 2008-04-17
CZ298174B6 (cs) 2007-07-11
BR9713192A (pt) 1999-12-21
AU4331797A (en) 1998-03-26
SI0927165T1 (en) 2004-04-30
SK285278B6 (sk) 2006-10-05
CN1537846A (zh) 2004-10-20
JP2001500495A (ja) 2001-01-16
AP2003002938A0 (en) 2003-12-31
ATE254603T1 (de) 2003-12-15
BG103305A (en) 2000-01-31
AU766155B2 (en) 2003-10-09
BG64793B1 (bg) 2006-04-28
DE69734689D1 (de) 2005-12-22
TR199900473T2 (xx) 1999-06-21
ES2210573T3 (es) 2004-07-01
IS4982A (is) 1999-02-19
NZ334909A (en) 2000-06-23
UA67727C2 (uk) 2004-07-15
WO1998009951A2 (en) 1998-03-12
HUP0000028A3 (en) 2003-05-28
NO991072L (no) 1999-03-04
DE69726298D1 (de) 2003-12-24
AU740369B2 (en) 2001-11-01
ATE309990T1 (de) 2005-12-15
CA2264756A1 (en) 1998-03-12
AP1322A (en) 2004-11-04
PT927165E (pt) 2004-04-30
DE69734689T2 (de) 2006-06-08
CN1305854C (zh) 2007-03-21
CZ298175B6 (cs) 2007-07-11

Similar Documents

Publication Publication Date Title
US5705647A (en) Intermediates for making HIV-protease inhibitors
US6605721B2 (en) Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
US6316625B1 (en) Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
SK284899B6 (sk) Medziprodukty na výrobu inhibítorov HIV-proteázy a spôsoby výroby inhibítorov HIV-proteázy
FR2634207A1 (fr) Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
US6084107A (en) Intermediates for making HIV-protease inhibitors
MXPA99002152A (en) Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors
JPH0780812B2 (ja) アズレン誘導体トロンボキサンシンセタ−ゼ阻害剤及びその製法
JPH07215968A (ja) アゼラスチンの製造方法
CA2549271A1 (en) Methods of making hiv-protease inhibitors and intermediates for making them
JPH02167263A (ja) 新規ジヒドロピリジン誘導体
JPH02300154A (ja) 安息香酸誘導体の製造法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090904